Progyny, Inc. Announces Details for Its Third Quarter Results Report

Rhea-AI Summary

Progyny, a leader in fertility benefits management, is scheduled to report its financial results for Q3 2020 on Nov. 5, 2020, after market close. A conference call will follow at 4:45 PM ET, accessible via specific dialing numbers for U.S. and international participants. An audio replay will be available until Nov. 12, 2020. Progyny is recognized for its innovative fertility solutions, enhancing access for patients while reducing healthcare costs for employers. With headquarters in New York, the company is gaining attention for its impact on fertility benefits.

Positive

• Scheduled Q3 2020 financial results announcement on November 5, 2020.
• Hosting a conference call for transparent investor communication.

Negative

• None.

NEW YORK, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended September 30, 2020 after the close of the market on Thursday, November 5, 2020.

The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.

Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.

An audio replay of the call will be available through Thursday, November 12, 2020 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.

A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians. 

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com

FAQ

When will Progyny report its Q3 2020 financial results?

Progyny will report its Q3 2020 financial results on November 5, 2020.

What time is the Progyny conference call scheduled?

The conference call is scheduled for 4:45 PM Eastern Time on November 5, 2020.

How can I access the Progyny conference call?

The conference call can be accessed by dialing 1.866.825.7331 for U.S. participants and 1.973.413.6106 for international participants.

Is there an option to replay the Progyny conference call?

Yes, an audio replay of the call will be available until November 12, 2020.

What is the main focus of Progyny as a company?

Progyny focuses on fertility and family building benefits management in the U.S.